Debora Barton's most recent trade in Tscan Therapeutics Inc was a trade of 430,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 13, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tscan Therapeutics Inc | Debora Barton | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 430,000 | 430,000 | - | - | Stock Option (Right to Buy) | |
| Tscan Therapeutics Inc | Debora Barton | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Tscan Therapeutics Inc | Debora Barton | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 150,000 | 150,000 | - | - | Stock Option (right to buy) |